IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA)

CompletedOBSERVATIONAL

Enrollment

753

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

March 30, 2022

Conditions

Kidney Transplantation

Interventions

DIAGNOSTIC_TEST

anti-spike SARS-CoV-2 IgG

Immunochemiluminescent assay by DiaSorin S.p.A. Italy

Trial Locations (1)

Institute for Clinical and Experimental Medicine, Prague

All Listed Sponsors

lead

Institute for Clinical and Experimental Medicine

OTHER_GOV

NCT04832841 - IgG Antibodies After SARS-CoV-2 mRNA Vaccine in Kidney Transplantation (TASMANIA) | Biotech Hunter | Biotech Hunter